WAVEMAN · COMPANY

PMI · Picard Medical, Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

PMI

Name: Picard Medical, Inc. (PMI) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Picard Medical, Inc.

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0002030617

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+12.5%

XBRL, annual

NET MARGIN

-546.6%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

37 funds added or opened last quarter

below 67% of Medical Devices

REVENUE

+12.5% year over year

more than 60% of Medical Devices

MARGIN

-546.6% net margin

below 94% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

37 funds added or opened positions in the latest 13F quarter, of 41 holders.

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 37 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Picard Medical, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

VANGUARD CAPITAL MANAGEMENT LLC

2,518,400.0 sh

$413.0K

AQR CAPITAL MANAGEMENT LLC

2,144,986.0 sh

$350.7K

JANE STREET GROUP, LLC

1,377,216.0 sh

$225.2K

IEQ CAPITAL, LLC

290,575.0 sh

$47.5K

RENAISSANCE TECHNOLOGIES LLC

172,381.0 sh

$28.2K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

iShares Micro-Cap ETF

$12.9K POSITION · AS OF 2026-03-31

0.0%

1290 VT Micro Cap Portfolio

$1.2K POSITION · AS OF 2026-03-31

0.0%

VANGUARD RUSSELL 2000 GROWTH INDEX FUND

$5.1K POSITION · AS OF 2026-02-28

0.0%

Fidelity Small Cap Growth Index Fund

$2.6K POSITION · AS OF 2026-03-31

0.0%

Venerable Small Cap Index Fund

$408 POSITION · AS OF 2026-03-31

0.0%

VANGUARD RUSSELL 2000 INDEX FUND

$26.2K POSITION · AS OF 2026-02-28

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12
REVENUE	$4.9M	$4.4M
GROSS PROFIT	$-204.0K	$-112.0K
OPERATING INCOME	$-13.3M	$-13.7M
NET INCOME	$-27.0M	$-21.1M
EPS (DILUTED)	-0.75	-2.99
OPERATING CASH FLOW	$-15.7M	$-11.9M
CASH	$7.5M	$96.0K

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE